Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation

Kai Syin Lee1, Anastasia Kalantzis, Cameron B Jackson

  • 1Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.

Plos One
|February 8, 2012
PubMed
Abstract

Insights

Helicobacter pylori (H. pylori) CagA protein triggers Regenerating islet-derived (REG)3γ expression in the stomach. This CagA-induced REG3γ response may help H. pylori survive by inhibiting competing Gram-positive bacteria.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) cytotoxin CagA is linked to gastric inflammation and cancer.
  • The role of CagA in H. pylori-infected individuals without cancer, particularly regarding host tolerance, is understudied.
  • Regenerating islet-derived gamma (REG3γ) is a C-type lectin with bactericidal activity against Gram-positive bacteria in the intestine.

Purpose of the Study:

  • To investigate the role of CagA in regulating REG3γ expression in the H. pylori-infected stomach.
  • To elucidate the molecular mechanisms underlying CagA-induced REG3γ expression.
  • To understand how H. pylori may manipulate host immunity for its survival.

Main Methods:

  • Analysis of REG3γ expression in human gastric mucosal tissues from H. pylori-infected individuals.
  • In vitro studies using CagA-inducible gastric MKN28 cells.
  • Investigation of signaling pathways including gp130, STAT3, IL-11, IL-6, SHP2, Ras, and ERK.

Main Results:

  • REG3γ expression was significantly increased in CagA-positive compared to CagA-negative H. pylori infected individuals.
  • Tyrosine-phosphorylated CagA, not unphosphorylated CagA, triggers REG3γ transcription.
  • CagA-induced REG3γ expression is mediated by the IL-11/gp130/STAT3 signaling pathway, while the SHP2-(Ras)-ERK pathway is not involved.

Conclusions:

  • CagA directs REG3γ expression in gastric epithelial cells via the IL-11/gp130/STAT3 pathway.
  • This host response may enable H. pylori to reduce competition from Gram-positive bacteria in the gastric niche.
  • H. pylori may manipulate host immunity to enhance its own survival.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...